Stent developer ITGI Medical Ltd. (TASE:ITGI) said today that it received the CE Mark for two lines of stents. The company also received ISO 13485 authorization, a quality standard designation for medical devices.
The two stent families that received the mark are its Over and Under line, and its AneuGraft line.
ITGI said that it met the requirements after, among other things, changes in the European standard.
Or Akiva-based ITGI develops heterologous tissue covered stents for cardiovascular and neurovascular use.
ITGI shares rose 4.75% in late morning trading. The shares have risen about 22% in September.
Published by Globes [online], Israel business news - www.globes-online.com - on September 16, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010